Tumor necrosis factor-α synthesis inhibitor, 3,6′- dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice

Journal of Neurochemistry

Volumn 118, Issue 6, 2011, Pages 1032-1042

  Baratz, Renana ^a   Tweedie, David ^b   Rubovitch, Vardit ^a   Luo, Weiming ^b   Yoon, Jeong Seon ^b   Hoffer, Barry J ^c,d   Greig, Nigel H ^b   Pick, Chaim G ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Intramural Research Program   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

etanercept; neuroinflammation; thalidomide; thiothalidomide; TNF ; traumatic brain injury

Indexed keywords

3,6' DITHIOTHALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG MEGADOSE; LOW DRUG DOSE; MALE; MAZE TEST; MOUSE; NEUROPROTECTION; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY; VISUAL MEMORY;

ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN CHEMISTRY; BRAIN INJURIES; CELL LINE; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED ICR; RECOGNITION (PSYCHOLOGY); THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 79961047459     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07377.x     Document Type: Article

References (71)

1. Andersson M., Svenungsson E., Khademi M., Lampa J., Brundin L., and, Wallström E., (2006) No signs of immunoactivation in the cerebrospinal fluid during treatment with infliximab. Ann. Rheum. Dis. 65, 1237-1240. (Pubitemid 44277405)
2. Aragon-Ching J. B., Li H., Gardner E. R., and, Figg W. D., (2007) Thalidomide analogues as anticancer drugs. Recent Pat. Anticancer Drug Discov. 2, 167-174. (Pubitemid 46952433)
3. Baratz R., Rubovitch V., Frenk H., and, Pick C. G., (2010) The influence of alcohol on behavioral recovery after mTBI in mice. J. Neurotrauma 27, 555-563.
4. Bryant R. A., O'Donnell M. L., Creamer M., McFarlane A. C., Clark C. R., and, Silove D., (2010) The psychiatric sequelae of traumatic injury. Am. J. Psychiatry 167, 312-320.
5. Cederberg D., and, Siesjö P., (2010) What has inflammation to do with traumatic brain injury? Childs Nerv. Syst. 26, 221-226.
6. Cernak I., and, Noble-Haeusslein L. J., (2010) Traumatic brain injury: an overview of pathobiology with emphasis on military populations. J. Cereb. Blood Flow Metab. 30, 255-266.
7. Dellu F., Mayo W., Cherkaoui J., Le Moal M., and, Simon H., (1992) A two-trial memory task with automated recording: study in young and aged rats. Brain Res., 588, 132-139.
8. Dix S. L., and, Aggleton J. P., (1999) Extending the spontaneous preference test of recognition: Evidence of object-location and object-context recognition. Behav. Brain Res. 99, 191-200. (Pubitemid 29083445)
9. Edut S., Rubovitch V., Schreiber S., and, Pick C. G., (2010) The intriguing effects of ecstasy (MDMA) on cognitive function in mice subjected to a minimal traumatic brain injury (mTBI). Psychopharmacol (Berl). 214, 877-889.
10. Esposito E., and, Cuzzocrea S., (2009) TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma. Curr. Med. Chem. 16, 3152-3167.
11. Frank-Cannon T. C., Alto L. T., McAlpine F. E., and, Tansey M. G., (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener. 4, 47.
12. Frankola K. A., Greig N. H., Luo W., and, Tweedie D., (2011) Targeting TNF-alpha to elucidate and ameliorate neuroinflammation in neurodegenerative diseases. CNS Neurol. Disord. Drug Targets, 10, 391-403.
13. Garner J., and, Brett S. J., (2007) Mechanisms of injury by explosive devices. Anesthesiol. Clin., 25, 147-160. (Pubitemid 46497890)
14. Ghajar J., Ivry R. B., and Cognitive and Neurobiological Research Consortium. (2008) The predictive brain state: timing deficiency in traumatic brain injury? Neurorehabil. Neural Repair 22, 217-227. (Pubitemid 351561670)
15. Greig N. H., Giordano T., Zhu X., Yu Q. S., Perry T. A., Holloway H. W., Brossi A., Rogers J. T., Sambamurti K., and, Lahiri D. K., (2004) Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases. Acta Neurobiol. Exp. 64, 1-9. (Pubitemid 38453801)
16. Hesdorffer D. C., Rauch S. L., and, Tamminga C. A., (2009) Long-term psychiatric outcomes following traumatic brain injury: a review of the literature. J. Head Trauma Rehabil. 24, 452-459.
17. Hyakkoku K., Nakajima Y., Izuta H., Shimazawa M., Yamamoto T., Shibata N., and, Hara H., (2009) Thalidomide protects against ischemic neuronal damage induced by focal cerebral ischemia in mice. Neuroscience 159, 760-769.
18. Israelsson C., Wang Y., Kylberg A., Pick C. G., Hoffer B. J., and, Ebendal T., (2009) Closed head injury in a mouse model results in molecular changes indicating inflammatory responses. J. Neurotrauma, 26, 1307-1314.
19. Johnson V. E., Stewart W., and, Smith D. H., (2010) Traumatic brain injury and amyloid-beta pathology: a link to Alzheimer's disease? Brain Pathol. Published Online doi: 10.1111/j.1750-3639.2011.00513.x.
20. Khera T. K., Dick A. D., and, Nicholson L. B., (2010) Mechanisms of TNFα regulation in uveitis: focus on RNA-binding proteins. Prog. Retin. Eye Res. 29, 610-625.
21. Kiraly M., and, Kiraly S. J., (2007) Traumatic brain injury and delayed sequelae: a review - traumatic brain injury and mild traumatic brain injury (concussion) are precursors to later-onset brain disorders, including early-onset dementia. ScientificWorldJournal 7, 1768-1776. (Pubitemid 350292615)
22. Knight R., (2005) IMiDs: a novel class of immunomodulators. Semin. Oncol. 32 (4 Suppl. 5), S24-S30. (Pubitemid 41111987)
23. Knoblach S. M., Fan L., and, Faden A. I., (1999) Early neuronal expression of tumor necrosis factor-α after experimental brain injury contributes to neurological impairment. J. Neuroimmunol., 95, 115-125. (Pubitemid 29173028)
24. Koopmans G. C., Deumens R., Buss A., Geoghegan L., Myint A. M., Honig W. H., Kern N., Joosten E. A., Noth J., and, Brook G. A., (2009) Acute rolipram/thalidomide treatment improves tissue sparing and locomotion after experimental spinal cord injury. Exp. Neurol. 216, 490-498.
25. Lecca D., Trincavelli M. L., Gelosa P., et al. (2008) The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair. PLoS ONE 3 (10), e3579.
26. Lee C. J., Kim K. W., Lee H. M., Nahm F. S., Lim Y. J., Park J. H., and, Kim C. S., (2007) The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model. Spinal Cord 45, 149-157. (Pubitemid 46204263)
27. Lu J., Goh S. J., Tng P. Y., Deng Y. Y., Ling E. A., and, Moochhala S., (2009) Systemic inflammatory response following acute traumatic brain injury. Front. Biosci. 14, 3795-3813.
28. Luo W., Yu Q. S., Tweedie D., Deschamps J., Parrish D, Holloway H. W., Li Y., Brossi A., and, Greig N. H., (2008) Syntheses of aromatic substituted 6'-thiothalidomides. Synthesis 21, 3415-3422.
29. McTighe S. M., Cowell R. A., Winters B. D., Bussey T. J., and, Saksida L. M., (2010) Paradoxical false memory for objects after brain damage. Science 330, 1408-1410.
30. Melchert M., and, List A., (2007) The thalidomide saga. Int. J. Biochem. Cell Biol. 39, 1489-1499. (Pubitemid 47031027)
31. Messier C., (1997) Object recognition in mice: improvement of memory by glucose. Neurobiol. Learn. Mem. 67, 172-175. (Pubitemid 27424472)
32. Milman A., Rosenberg A., Weizman R., and, Pick C. G., (2005) Mild traumatic brain injury induces persistent cognitive deficits and behavioral disturbances in mice. J. Neurotrauma 22, 1003-1010. (Pubitemid 41362066)
33. Moppett I. K., (2007) Traumatic brain injury: assessment, resuscitation and early management. Br. J. Anaesth. 99, 18-31. (Pubitemid 47082215)
34. Moreira A. L., Sampaio E. P., Zmuidzinas A., Frindt P., Smith K. A., and, Kaplan G., (1993) Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J. Exp. Med. 177, 1675-1680. (Pubitemid 23146134)
35. Pan W., Kastin A. J., Rigai T., McLay R., and, Pick C. G., (2003) Increased hippocampal uptake of tumor necrosis factor alpha and behavioral changes in mice. Exp. Brain Res. 149, 195-199. (Pubitemid 36315369)
36. Patil C. S., Liu M., Zhao W., Coatney D. D., Li F., VanTubergen E. A., D'Silva N. J., and, Kirkwood K. L., (2008) Targeting mRNA stability arrests inflammatory bone loss. Mol. Ther. 16, 1657-1664.
37. Raghupathi R., (2004) Cell death mechanisms following traumatic brain injury. Brain Pathol. 14, 215-222. (Pubitemid 38656395)
38. Reale M., Greig N. H., and, Kamal M. A., (2009) Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases. Mini Rev. Med. Chem. 9, 1229-1241.
39. Reyes-Alva H. J., Franco-Bourland R. E., Martínez-Cruz A., Grijalva I., Fuchs B., Madrazo I., and, Guízar-SahagÃn G., (2009) Thalidomide fails to be therapeutic following contusive spinal cord injury in rats. Acta Neurobiol. Exp. 69, 494-503.
40. Rubovitch V., Edut S., Sarfstein R., Werner H., and, Pick C. G., (2010) The intricate involvement of the insulin-like growth factor receptor signaling in mild traumatic brain injury in mice. Neurobiol. Dis. 38, 299-303.
41. Sampaio E. P., Sarno E. N., Galilly R., Cohn Z. A., and, Kaplan G., (1991) Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J. Exp. Med. 173, 699-703.
42. Scherbel U., Raghupathi R., Nakamura M., Saatman K. E., Trojanowski J. Q., Neugebauer E., Marino M. W., and, McIntosh T. K., (1999) Differential acute and chronic responses of tumor necrosis factor- deficient mice to experimental brain injury. Proc. Natl Acad. Sci. USA 96, 8721-8726. (Pubitemid 29354858)
43. Shannon E. J., and, Sandoval F., (1996) Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mono-nuclear cells. Immunopharmacol. Immunotoxicol. 18, 59-72. (Pubitemid 26099057)
44. Shohami E., Novikov M., Bass R., Yamin A., and, Gallily R., (1994) Closed head injury triggers early production of TNF-α and IL-6 by brain tissue. J. Cereb. Blood Flow Metab. 14, 615-619. (Pubitemid 24198404)
45. Shohami E., Bass R., Wallach D., Yamin A., and, Gallily R., (1996) Inhibition of tumor necrosis factor alpha (TNF-alpha) activity in rat brain is associated with cerebroprotection after closed head injury. J. Cereb. Blood Flow Metab. 16, 378-384. (Pubitemid 26125326)
46. Shohami E., Gallily R., Mechoulam R., Bass R., and, Ben-Hur T., (1997) Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-α inhibitor and an effective neuroprotectant. J. Neuroimmunol. 72, 169-177. (Pubitemid 27062773)
47. Stahel P. F., Shohami E., Younis F. M., et al. (2000) Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J. Cereb. Blood Flow Metab. 20, 369-380. (Pubitemid 30108456)
48. Stamou P., and, Kontoyiannis D. L., (2010) Posttranscriptional regulation of TNF mRNA: a paradigm of signal-dependent mRNA utilization and its relevance to pathology. Curr. Dir. Autoimmun. 11, 61-79.
49. Stoica B. A., and, Faden A. I., (2010) Cell death mechanisms and modulation in traumatic brain injury. Neurotherapeutics 7, 3-12.
50. Sullivan P. G., Bruce-Keller A. J., Rabchevsky A. G., Christakos S., Clair D. K., Mattson M. P., and, Scheff S. W., (1999) Exacerbation of damage and altered NF-ÎB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury. J. Neurosci. 19, 6248-6256. (Pubitemid 29347425)
51. Svetlovey S. I., Larner S. F., Kirk D. R., Atkinson J., Hayes R. L., and, Wang K. K., (2009) Biomarkers of blast-induced neurotrauma: profiling molecular and cellular mechanisms of blast brain injury. J. Neurotrauma 26, 913-921.
52. Tadesse A., Abebe M., Bizuneh E., Mulugeta W., Aseffa A., and, Shannon E. J., (2006) Effect of thalidomide on the expression of TNF-alpha m-RNA and synthesis of TNF-alpha in cells from leprosy patients with reversal reaction. Immunopharmacol. Immunotoxicol. 28, 431-441. (Pubitemid 44451572)
53. Tansey M. G., (2010) Inflammation in neuropsychiatric disease. Neurobiol. Dis. 37, 491-492.
54. Tansey M. G., and, Szymkowski D. E., (2009) The TNF superfamily in 2009: new pathways, new indications, and new drugs. Drug Discov. Today 14, 1082-1088.
55. Tashlykov V., Katz Y., Volkov A., Gazit V., Schreiber S., Zohar O., and, Pick C. G., (2009) Minimal traumatic brain injury induce apoptotic cell death in mice. J. Mol. Neurosci. 37, 16-24.
56. Taupin V., Toulmond S., Serrano A., Benavides J., and, Zavala F., (1993) Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion: influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand. J. Neuroimmunol. 42, 177-185.
57. Taylor P. C., (2010) Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases. Curr. Opin. Pharmacol. 10, 308-315.
58. Teo S. K., Colburn W. A., Tracewell W. G., Kook K. A., Stirling D. I., Jaworsky M. S., Scheffler M. A., Thomas S. D., and, Laskin O. L., (2004) Clinical pharmacokinetics of thalidomide. Clin. Pharmacokinet. 43, 311-327. (Pubitemid 38534754)
59. Tobinick E., (2010) Perispinal etanercept: a new therapeutic paradigm in neurology. Exp. Rev. Neurother. 10, 985-1002.
60. Tweedie D., Milman A., Holloway H. W., et al. (2007a) Apoptotic and behavioral sequelae of mild brain trauma in mice. J. Neurosci. Res. 85, 805-815. (Pubitemid 46426080)
61. Tweedie D., Sambamurti K., and, Greig N. H., (2007b) TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets. Curr. Alzheimer Res. 4, 378-385. (Pubitemid 47421968)
62. Tweedie D., Luo W., Short R. G., Brossi A., Holloway H. W., Li Y., Yu Q. S., and, Greig N. H., (2009) A cellular model of inflammation for identifying TNF-alpha synthesis inhibitors. J. Neurosci. Methods 183, 182-187.
63. Tweedie D., Frankola K. A., Luo W., Li Y., and, Greig N. H., (in press) Thalidomide analogues suppress lipopolysaccharide-induced synthesis of TNF-α and nitrite, an intermediate of nitric oxide, in a cellular model of inflammation. Open Biochem. J. (in press).
64. Uryu K., Giasson B. I., Longhi L., et al. (2003) Age-dependent synuclein pathology following traumatic brain injury in mice. Exp. Neurol. 184, 214-224. (Pubitemid 37444032)
65. Vakil E., (2005) The effect of moderate to severe traumatic brain injury (TBI) on different aspects of memory: a selective review. J. Clin. Exp. Neuropsychol. 27, 977-1021. (Pubitemid 41527533)
66. Yan Y. P., Lang B. T., Vemuganti R., and, Dempsey R. J., (2009) Galectin-3 mediates post-ischemic tissue remodeling. Brain Res. 1288, 116-124.
67. Yang J., You Z., Kim H. H., Hwang S. K., Khuman J., Guo S., Lo E. H., and, Whalen M. J., (2010) Genetic analysis of the role of tumor necrosis factor receptors in functional outcome after traumatic brain injury in mice. J. Neurotrauma 27, 1037-1046.
68. Zhou Q. H., Boado R. J., Hui E. K., Lu J. Z., and, Pardridge W. M., (2011) Brain-penetrating tumor necrosis factor decoy receptor in the mouse. Drug Metab. Dispos. 39, 71-6.
69. Zhu X., Giordano T., Yu Q. S., Holloway H. W., Perry T. A., Lahiri D. K., Brossi A., and, Greig N. H., (2003) Thiothalidomides: novel isosteric analogues of thalidomide with enhanced TNF-alpha inhibitory activity. J. Med. Chem. 46, 5222-5229. (Pubitemid 37414191)
70. Ziebell J. M., and, Morganti-Kossmann M. C., (2010) Involvement of pro- and anti-inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7, 22-30.
71. Zohar O., Schreiber S., Getslev V., Schwartz J. P., Mullins P. G., and, Pick C. G., (2003) Closed-head minimal traumatic brain injury produces long-term cognitive deficits in mice. Neuroscience 118, 949-955. (Pubitemid 36561183)